The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure
- 190 Downloads
The validity of epidemiological studies assessing a lifetime cancer risk due to environmental factors, such as nutrition or smoking behavior strongly depends on the validity of the patient’s history.
This study assesses whether a standardized questionnaire is a valid tool to identify exposure with acrylamide by relating the self-reported food and smoking history with a biomarker, namely hemoglobin-adduct levels of acrylamide.
Objective parameters of previous exposure, such as hemoglobin-adduct levels of acrylamide and of the smoking-specific acrylonitrile, respectively, were related to self-reported data in 1,008 volunteers of the general population in bivariate analyses and a multiple linear regression analysis using the log-transformed biomarker levels as outcome.
Smoking was significantly associated with adduct levels of acrylamide (p < 0.0001) and had a main contribution to the internal burden with acrylamide. In cigarette smokers a strong correlation between the number of cigarettes smoked daily and the corresponding biomarkers was observed. Focusing on non-smokers (n = 828), a significant but weak correlation was found in bivariate analyses (Spearman rank correlation coefficient: 0.178 (95% CI: 0.089–0.268) in females and 0.168 (95% CI: 0.063–0.273) in males. A multiple linear regression analysis similarly yielded evidence of a significant association between the highest intake category and adduct levels; however, explained variability was very small (R2 = 0.08).
Self-reported data concerning smoking behavior were highly valid, while self-reported food intake is apparently not as useful for estimating food-related acrylamide exposure.
KeywordsAcrylamide Exposure assessment Hemoglobin adducts Validity of self-reported data
- 2.Rice JM (2005) The carcinogenity of acrylamide. Mut Resear 580:3–20Google Scholar
- 16.BfR Bundesinstitut für Risikobewertung: 2 Jahre Acrylamid – Eine Bilanz aus der Sicht der Risikobewertung, Stellungnahme vom 19.3.2004 (In German)Google Scholar
- 22.Hagmar L, Törnqvist M, Nordander C, Rosen I, Bruze M, Kautianinen A, Magnusson AL, Malmberg B, Aprea P, Granath F, Axmon A (2001) Health effects of occupational exposure to acrylamide using haemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health 27:219–226PubMedGoogle Scholar
- 29.Heitmann BL, Lissner L (1995) Dietary underreporting by obese individuals––is it specific or non-specific? Br Med J 311:986–989Google Scholar
- 30.Lafay L, Mennen L, Basdevant A, Charles MA, Borys JM, Eschwege E, Romon M (2000) Does energy intake underreporting involve all kinds of food or only specific food items. Results from the Fleurbaix Laventie Ville Sante (FLVS) study. Int J Obes Relat Metab Disord 24:1500–1506PubMedCrossRefGoogle Scholar
- 37.Bingham SA (1991) Validation of dietary assessment through biomarkers. Biomarkers of dietary exposure. In: Kok AP, van’t Veer P (eds) Proceedings of the 3rd meeting on nutritional epidemiology, Smith-Gordon, London pp 41–52Google Scholar
- 38.Hagmar L, Wirfällt E, Paulsson B, Törnqvist M (2005) Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mut Res 580:157–165Google Scholar